Earnings calendar/LFCR
LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)
Quarter-by-quarter results read from the company's own filed statements — period end, filing date, diluted EPS, revenue and year-over-year change. Consensus estimates are shown only where one exists.
Latest filed quarter
The most recent quarter LIFECORE BIOMEDICAL, INC. \DE\ has filed, from EvidInvest's standardized statements.
Period end
Dec 31, 2026
Q4 FY2026
Filed
Mar 16, 2026
Filing date on record
EPS (diluted)
$-0.19
No estimate on record
Revenue
$34.2M
As filed
Net income
$-6.2M
As filed
EPS YoY
-216.7%
vs quarter ended 2025-05-25
Revenue YoY
-6.2%
vs quarter ended 2025-05-25
Next report
Nov 5, 2026
Estimated from filing cadence, ± 3 days
Run-rate
Trailing twelve months, summed from the last four filed quarters.
TTM EPS (diluted)
$-0.77
2025-12-31 through 2026-12-31
TTM revenue
$122.3M
2025-12-31 through 2026-12-31
Filed quarters
40
On record here
EPS at or above estimate (4Q)
75%
Of the last four quarters that carry an estimate
Filed quarters
One row per filed statement, newest first
| Period end | Filed | EPS diluted | Revenue | EPS YoY | Revenue YoY | Est. EPS | Surprise |
|---|---|---|---|---|---|---|---|
| 2026-12-31Q4 FY2026 | 2026-03-16 | $-0.19 | $34.2M | -216.7% | -6.2% | — | — |
| 2026-06-30Q4 FY2026 | 2026-08-05 | $-0.19 | $34.2M | -216.7% | -6.2% | $-0.19 | 0.0% |
| 2026-03-31Q3 FY2026 | 2026-05-06 | $-0.43 | $23.2M | -2.4% | -34.0% | $-0.27 | -59.3% |
| 2025-12-31Q4 FY2026 | 2026-03-16 | $0.04 | $30.8M | +166.7% | -15.6% | $-0.29 | +113.8% |
| 2025-09-30Q1 FY2026 | 2025-11-06 | $-0.29 | $31.1M | +45.3% | +25.9% | $-0.30 | +3.3% |
| 2025-05-25Q4 FY2025 | 2026-08-05 | $-0.06 | $36.4M | +53.8% | -3.8% | $-0.09 | +33.3% |
| 2025-02-23Q3 FY2025 | 2025-04-03 | $-0.42 | $35.2M | -200.0% | -1.5% | $-0.14 | -200.0% |
| 2024-11-24Q2 FY2025 | 2025-01-02 | $-0.25 | $32.6M | -164.1% | +8.0% | $-0.27 | +7.4% |
| 2024-08-25Q1 FY2025 | 2024-10-04 | $-0.53 | $24.7M | -51.4% | +0.7% | $-0.12 | -341.7% |
| 2024-05-26Q4 FY2024 | 2024-08-26 | $-0.13 | $37.9M | +90.2% | +21.6% | $-0.12 | -8.3% |
| 2024-02-25Q3 FY2024 | 2024-08-09 | $0.42 | $35.7M | +135.0% | +34.5% | $0.07 | +500.0% |
| 2023-11-26Q2 FY2024 | 2024-08-09 | $0.39 | $30.1M | +190.7% | +37.9% | $-0.23 | +269.6% |
| 2023-08-27Q1 FY2024 | 2024-08-09 | $-0.35 | $24.5M | +5.4% | +3.4% | $-0.37 | +5.4% |
| 2023-05-28Q4 FY2023 | 2024-03-20 | $-1.32 | $31.1M | +29.8% | +10.8% | $-0.13 | -915.4% |
| 2023-02-26Q3 FY2023 | 2023-06-02 | $-1.20 | $26.5M | -172.7% | -50.0% | $-0.04 | -2900.0% |
| 2022-11-27Q2 FY2023 | 2023-03-16 | $-0.43 | $21.9M | +66.9% | -83.1% | — | — |
| 2022-08-28Q1 FY2023 | 2022-10-07 | $-0.37 | $23.7M | -15.6% | -81.6% | $-0.13 | -184.6% |
| 2022-05-29Q4 FY2022 | 2022-09-14 | $-1.88 | $28.1M | -1780.0% | -79.9% | $-0.01 | -18700.0% |
| 2022-02-28Q3 FY2022 | 2022-02-28 | $-0.44 | $53.1M | -83.3% | +90.9% | $0.01 | -4500.0% |
| 2022-02-27Q3 FY2022 | 2022-04-07 | $-0.46 | $35.2M | -91.7% | +26.7% | — | — |
| 2021-11-30Q2 FY2022 | 2021-11-30 | $-1.30 | $129.5M | -188.9% | -1.1% | $-0.04 | -3150.0% |
| 2021-11-28Q2 FY2022 | 2022-01-07 | $-1.31 | $25.6M | -191.1% | -80.4% | — | — |
| 2021-08-31Q1 FY2022 | 2022-02-28 | $-0.32 | $128.8M | +15.8% | -5.1% | $-0.12 | -166.7% |
| 2021-08-29Q1 FY2022 | 2021-10-05 | $-0.32 | $22.3M | +15.8% | -83.5% | — | — |
| 2021-05-31Q4 FY2021 | 2021-05-31 | $-0.10 | $139.8M | +80.8% | -10.4% | $0.01 | -1638.5% |
| 2021-05-30Q4 FY2021 | 2021-07-29 | $-0.03 | $44.9M | +94.2% | -71.2% | — | — |
| 2021-02-28Q3 FY2021 | 2021-04-08 | $-0.24 | $27.8M | +38.5% | -81.8% | $-0.02 | -1428.7% |
| 2020-11-30Q2 FY2021 | 2020-11-30 | $-0.45 | $130.9M | -95.7% | -8.2% | $0.01 | -4600.0% |
| 2020-11-29Q2 FY2021 | 2021-01-07 | $-0.40 | $23.8M | -73.9% | -83.3% | — | — |
| 2020-08-31Q1 FY2021 | 2021-02-28 | $-0.38 | $135.6M | -137.5% | -2.2% | $-0.11 | -245.5% |
| 2020-08-30Q1 FY2021 | 2020-10-07 | $-0.42 | $22.7M | -162.5% | -83.7% | — | — |
| 2020-05-31Q4 FY2020 | 2020-08-14 | $-0.52 | $156.1M | -5100.0% | +2.2% | $0.03 | -1990.9% |
| 2020-02-29Q3 FY2020 | 2020-02-29 | $-0.39 | $152.9M | -143.8% | +10.2% | $0.03 | -1660.0% |
| 2020-02-23Q3 FY2020 | 2020-04-03 | $-0.39 | $152.9M | -143.8% | +10.2% | — | — |
| 2019-11-30Q2 FY2020 | 2019-11-30 | $-0.23 | $142.6M | -2200.0% | -6.7% | $-0.06 | -283.3% |
| 2019-11-24Q2 FY2020 | 2020-01-02 | $-0.23 | $142.6M | -2400.0% | -6.7% | — | — |
| 2019-08-31Q1 FY2020 | 2020-02-29 | $-0.16 | $138.7M | — | — | $-0.16 | 0.0% |
| 2019-08-25Q1 FY2020 | 2019-10-03 | $-0.16 | $138.7M | — | — | — | — |
| 2019-05-31Q4 FY2019 | 2019-05-31 | $-0.01 | $152.8M | — | — | $-0.01 | -66.7% |
| 2019-05-26Q4 FY2019 | 2019-08-01 | $0.01 | $152.8M | — | — | — | — |
Need LFCR data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.